COVID-19
Abcepta manufactured the first research grade antibodies against coronavirus proteins in 2003.
Coronavirus-related product lines include:
- 30+ antibodies targeting multiple coronavirus proteins
- 950+ peptides from SARS and SARS-2 coronavirus proteins
- 2500+ host protein specific antibodies covering the viral life cycle
Abcepta continues to operate and ship worldwide, assuring your access to trusted reagents for urgent high-impact research during the COVID-19 pandemic.
Viral Entry and Processes
Innate Immunity
SARS CoV-2 PPIs
Cytokines and Inflammation






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.